News Sports Obituaries Classifieds Alert 91° Full Menu Alert 91° Home eEdition Customer Service Mobile & Apps Newsletters News All News Local News Local Traffic Cam State News Business Education NIE Crime More News Andrew Dys Nation/World Politics/Government Weird News Databases Down Home Magazine Physicians Directory Fort Mill Times Fort Mill Times Fort Mill Times Sports Submit a News Tip Submit a Letter to the Editor Sports All Sports Panthers College Winthrop High School High School Football Auto Racing Politics Politics Elections Obituaries Opinion All Opinion Editorial Letters to the Editor Submit a Letter To the Contrary James Werrell Palmetto Opinion Living All Living Community Weddings Engagements Anniversaries Births Religion Family Home & Garden Entertainment Entertainment All Entertainment Books Calendar Movies Music Puzzles & Games … [Read more...] about 11 charged in 2-state bust as FBI, DEA search 17 sites, including Rock Hill drug lab
Investigational new drug database
Brett Kelman The Tennessean Published 6:23 p.m. UTC May 21, 2018 It looks like just a few grains of salt, too small to taste, but hiding in these tiny white crystals is an unpredictable power to kill. This is fentanyl, the new deadliest drug in Nashville. Fentanyl killed more people than heroin in Davidson County for the first time ever last year, signaling that the core of the local opioid crisis has shifted to a new tier of powerful and dangerous drugs. As Tennessee has tightened its grip on prescription medication, many addicts have abandoned doctor shopping in favor of black market heroin and counterfeit pills that are often laced with fentanyl, a synthetic, cheap-to-produce, incredibly potent opioid that was once barely known outside of hospitals. For most people, two milligrams is a lethal dose. “The streets are being flooded with fentanyl, and it’s contaminating these other drugs – whether they are heroin, or cocaine or counterfeit … [Read more...] about For years, heroin has been the deadliest drug in Nashville. Not anymore.
WiseGuyReports.com adds “Human Growth Hormones Deficiency (GHD) Drugs Market 2018 Global Analysis Research Report Forecasting to 2025”reports to its database. PUNE, INDIA, April 25, 2018 /EINPresswire.com/ -- Human Growth Hormones Deficiency (GHD) Drugs Market: Executive Summary The report presents the market potential of four major pipeline drugs (TransCon-hGH, Somapacitan, Somavaratan, Somatrogonmeant) for the treatment of human Growth Hormone Deficiency (GHD). These four drugs that fall in the various categories of paediatrics and adults by end user have been recognized as being clinically effective in human Growth Hormone Deficiency treatment. Expected to be launched in the market within the next 4-5 years, these four potential drugs are likely to bring about major changes in the way Growth Hormone Deficiency is treated globally. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and … [Read more...] about Global Human Growth Hormones Deficiency (GHD) Drugs Market 2018 Size, Share, Growth, Trends, Analysis and Forecast -2023
Almost one-third of drugs approved by the U.S. Food and Drug Administration were flagged later for safety issues, new research reveals. But it doesn't necessarily mean drugs are approved too soon, says the study author. Researchers from Brigham and Women's Hospital in Boston, the Mayo Clinic and Yale School of Medicine analyzed data on 222 new drugs — 183 pharmaceuticals and 39 biologics — approved by the FDA between 2001 and 2010. Most drugs are pharmaceuticals, meaning they are created from small molecules using chemistry techniques. Biologics are produced from living organisms grown in labs. The study identified 123 drugs that had safety issues arise after FDA approval. Of those: 3 were withdrawn due to safety concerns 61 had received boxed warnings about serious side effects 59 had been flagged in FDA communications for safety issues "Just shy of one in three drugs encountered a post-market safety event," lead author Dr. Nicholas Downing, a resident physician … [Read more...] about CBS News Logo Drug safety issues often arise after FDA approval, new study finds
The Trump administration is looking to slash the White House Office of National Drug Control Policy (ONDCP) budget by nearly 95 percent, according to a memo obtained by CBS News. The Office of Management and Budget (OMB) has proposed major ONDCP budget cuts for fiscal year 2018 that would cut 33 employees, nearly half the office staff, along with intelligence, research and budget functions at the agency, as well as the Model State Drug Laws and Drug Court grant programs. The cuts were outlined in OMB's "passback" document, a part of the budget process where the Office instructs federal agencies to draw up preliminary budgets that are subject to Congressional approval. It was uploaded to MAX Collect, the OMB's budget database. The document also zeroes out funding to a number of grant programs including the High Intensity Drug Trafficking Areas (HIDTA) program and the Drug-free Communities Support Program. These grants are "duplicative of other efforts across the Federal … [Read more...] about CBS News Logo Trump administration proposes massive cuts to Drug Czar office